AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
1min snip
Microdosing, Big Pharma, and Weight Loss: Inside GLP-1 Agonists Ozempic, Wegovy, Zepbound and Others with Dr. Tyna Moore
The Doctor Youn Show
Caution in Diabetes Management
Pancreatitis presents significant risks, particularly for individuals with a history of biliary disease or gallstones, emphasizing the need for caution regardless of body composition or dosage. Type 2 diabetics, who are particularly susceptible to gastroparesis due to hyperglycemia damaging the vagus nerve, may experience temporary stomach issues when using GLP1 medications, but the adverse effects typically reverse after discontinuation. Additionally, concerns about muscle loss arise from severely low-calorie diets which can lead to lean mass reduction. However, GLP1 medications appear to possess muscle regenerative qualities by enhancing blood flow and facilitating amino acid delivery for protein synthesis, indicating that muscle degradation primarily results from calorie restriction rather than the medications themselves.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode